Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 1—January 2004


Human Infection with M- Strain of Brucella canis

Jorge C. Wallach*†Comments to Author , Guillermo H. Giambartolomei†, Pablo C. Baldi†, and Carlos A. Fossati†‡
Author affiliations: *Hospital F. J. Muñiz, Buenos Aires, Argentina; †IDEHU, Universidad de Buenos Aires, Buenos Aires, Argentina; ‡Universidad Nacional de La Plata, La Plata, Argentina

Main Article


Cellular immune response in vitro to Brucella cytoplasmic proteinsa

Antigen Lymphocyte proliferation (SI) IL-2b (fold increase) IFN-γb (fold increase) IL-10b (fold increase)
Before therapy BLS 4 8 3 3
CP 3 10 7 4.5
End of therapy BLS 1 1 2 1
CP 2.5 6 4 2
55 days after end
of therapy BLS 1 1 1 1
CP 1 1 3 1

aBLS, Brucella lumazine synthase; CP, cytoplasmic proteins; SI, stimulation indices; IL, interleukin; IFN, interferon.
bBy reverse transcription-polymerase chain reaction.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO